INCR
InterCure Ltd.
5.50$
+0.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 48.7% | 46.9% | 53.2% | 50.1% | 50.1% | 51.4% | 51.4% | 49.7% | 49.7% | 45.9% | 45.9% | 45.9% | |
| 12.1% | 12.2% | 12.9% | 2.7% | 2.7% | 10.3% | 10.3% | 6.8% | 6.8% | 6.7% | 6.7% | 6.7% | |
| 12.2% | 12.2% | 12.9% | 2.7% | 2.7% | 10.3% | – | 6.9% | 6.9% | 6.8% | – | 6.8% | |
| 19.3% | 16.0% | 7.8% | 8.3% | 8.3% | 6.9% | 6.8% | 6.2% | 6.2% | 3.2% | 3.1% | 22.4% | |
| 15.6% | 17.0% | 13.4% | 17.1% | 17.5% | 15.8% | 16.4% | 19.7% | 19.7% | 15.6% | 15.6% | 15.6% | |
| 11.6% | 11.5% | – | – | – | – | – | – | – | – | – | – | |
| 32.5% | 33.8% | 28.1% | 30.2% | 30.2% | 29.5% | 29.5% | 29.9% | 29.9% | 31.7% | 31.7% | 31.7% | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 40.3% | 37.3% | 41.9% | 37.6% | 37.6% | 47.9% | 47.9% | 42.5% | 42.5% | 42.6% | 42.6% | 42.6% | |
| 26.7% | 24.7% | 28.7% | 28.2% | 28.2% | 29.7% | 29.7% | 26.9% | 26.9% | 31.0% | 31.0% | 31.0% | |
| 8.8% | 6.8% | 11.8% | 11.0% | 11.0% | 9.7% | – | 8.3% | 8.3% | 15.1% | – | 15.1% | |
| 11.3% | 12.4% | 10.0% | 11.2% | 11.2% | 10.2% | 10.2% | 12.1% | 12.1% | 9.9% | 9.9% | 9.9% | |
| 11.0% | 10.0% | – | – | 6.9% | – | 14.9% | – | – | – | 8.6% | – | |
| 57.4% | 60.4% | 57.9% | 62.1% | 62.1% | 52.1% | 52.1% | 57.4% | 57.4% | 57.4% | 57.4% | 57.4% | |
| -16.2% | -16.2% | -25.9% | -27.6% | -27.6% | -36.4% | -36.4% | -37.2% | -37.2% | -45.6% | -45.6% | -45.6% | |
| 1.0% | 1.0% | 1.1% | 1.3% | 1.3% | 1.2% | 6.2% | 1.5% | 1.5% | 1.5% | 7.9% | 1.5% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.